Accueil / Display on home and articles
The French platform Cancer and Cognition is the first of its kind dedicated to the study and evaluation of the impact of cancer and its treatments on cognitive functions.
READ MORE
A unique model
A multidisciplinary consortium composed of specialists with comprehensive experience from preclinical testing to the post-cancer period.
OUR ORGANISATION
What is cognition?
Memory, thinking, learning, attention, language…
LEARN MORE
Findings
Cognitive impairment may persist for up to 20 years after chemotherapy.
OUR WORK
We are a multidisciplinary model

Clinical
expertise
In clinical trials: exploring the impact of cancer, treatments and patient care strategies…
.
LEARN MORE

Neuropsychological
expertise
Focus on cognitive and cerebral damage caused by cancer and cancer treatments
LEARN MORE

Preclinical and biomarkers
expertise
Evaluation and understanding of neurobiological mechanisms and behavioural effects induced by cancer and treatments in animals
LEARN MORE

Biostatistics
expertise
Study design and implementation, and data analysis
LEARN MORE
Do not miss, Do not miss, Do not miss, Do not miss, Do not miss, Non classé @en
“ Welcome to the cancer and cognition platform. We aim to provide our expertise on the impact of cancer and its treatments on cognitive functions to oncology intergroups, academic researchers and drug companies. “
Florence JOLY, MD-PhD, Oncologist
When cancer impacts memory
“Chemo fog” is a known condition shared by a number of patients treated with chemotherapy. It is a kind of fog which can alter concentration and be very disabling. Side effects associated with cancer, such as fatigue and memory disorders, are now better taken into account by oncologists. Around 5 min of video.
By the Allodocteurs.fr, 17/02/2011 editorial board